The trial will assess if direct outreach by healthcare providers increases cascade genetic testing among first-degree ...

So it's important to remember that all human beings have a risk of colorectal cancer. About 1 in 23 men will be diagnosed with colorectal cancer and about 1 in 25 women, but about 5 to 10% of those ...

Labcorp joins a national CRC trial as exclusive genetic testing provider, expanding Invitae-based testing and supporting ...

It’s increasingly common to see headlines and social media conversations about the rise in colorectal cancer among younger adults. In fact, the growing incidence of colorectal cancer in people under ...

Fact checked by Jennifer Klump Key Takeaways The American Cancer Society now recommends stool-based tests and a blood test as ...

The diagnosis of Lynch syndrome in patients with colorectal cancer has evolved from reliance on clinical criteria to integrated molecular and genetic approaches. Genetic testing strategies typically ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. March is Colon Cancer Awareness Month, an important time to ...

Immunotherapy wipes out some colorectal tumors without surgery, signaling a major shift toward less invasive treatment.

Biomarker testing in colorectal cancer (CRC) informs doctors about unique features of cancer that may influence its growth, spread, recurrence, and treatment response. Colorectal cancer (CRC), which ...

Lindsay Curtis is a health & medical writer in South Florida. She worked as a communications professional for health nonprofits and the University of Toronto’s Faculty of Medicine and Faculty of ...